Skip to main content
Medical information Clinical review pending

Endocrine Testing

Inhibin A Reproductive Marker Test

The Inhibin A Reproductive Marker Test measures levels of the Inhibin A hormone to help assess reproductive health and detect potential endocrine disorders. This test is particularly useful for individuals experiencing fertility issues or undergoing assisted reproductive technology.

General information only: This page is not a diagnosis or personal medical advice. A qualified clinician should decide whether testing is appropriate and interpret results in context.

Review status: No completed medical review is recorded for this page.

Ask a question
Counselor guidance included Confidential handling Kenya-wide coordination

At a glance

Plan your test

Sample
2 mL (1 mL minimum) serum collected in a Serum Separator Tube (SST).
Results
Confirm with the laboratory before booking.
Preparation
No special preparation is required for this test. Confirm with the laboratory before booking.
Test priceKSh 1,755

Payment: M-Pesa and card options can be confirmed during booking.

Insurance & government schemes

Is this test covered for you?

We help you verify whether the Inhibin A Reproductive Marker Test test can be claimed against your insurer, employer scheme or a Kenyan government health scheme — before you book. Coverage depends on your plan, clinical indication and your provider's rules; final approval always rests with them.

Talk to a claims advisor

Providers & schemes we can help you check

Government & public schemes

SHIF — Social Health Insurance Fund Linda Mama EduAfya NHIF (legacy cards)

Eligibility and benefits follow the current rules of the Social Health Authority (SHA) and applicable government programmes.

Private insurers & employer schemes

Jubilee Health AAR APA Britam CIC Madison Resolution Pioneer Minet Old Mutual GA Life Heritage + other licensed insurers

Names shown for identification only — listing does not imply partnership or guarantee of coverage.

Have these ready when we check

  • Insurer or scheme name & policy / member number
  • A clinician's request / prescription for the test
  • Pre-authorisation letter, if your plan requires one

Free coverage check

Ask us to verify your cover

Send your details and our claims team confirms what documents you need and whether pre-authorisation applies — usually the same working day.

+254

Used only to process your coverage check — see our Privacy Policy. Verification support is free and does not guarantee your provider will pay.

01

Start with fit

Is this the right test for you?

The best test starts with a clear clinical question. These are common reasons a clinician or family may consider this test.

  • ✓Infertility investigation
  • ✓Monitoring assisted reproductive technology (ART)
  • ✓Evaluating ovarian dysfunction
  • ✓Assessing risk for reproductive system disorders
  • ✓Investigating potential endocrine conditions
  • ✓Pre-menopausal women with specific symptoms
02

In plain language

What this test helps you understand

Assessing ovarian function, monitoring fertility treatments, investigating potential reproductive system disorders, and aiding in the diagnosis of certain endocrine conditions.
The Inhibin A Reproductive Marker Test is a diagnostic tool used to evaluate reproductive health and identify potential endocrine disorders. Inhibin A is a hormone primarily produced by the ovaries, playing a key role in regulating the menstrual cycle and fertility. This test is especially relevant for women facing fertility challenges or those undergoing assisted reproductive technology (ART).

This test measures the concentration of Inhibin A in a blood sample. Abnormal levels can sometimes indicate conditions affecting the reproductive system, such as ovarian dysfunction or certain types of tumors. It is often used alongside other hormone tests to provide a comprehensive assessment of ovarian function and overall reproductive health.

Consider discussing this test with your healthcare provider if you are experiencing difficulties with fertility, undergoing fertility treatments, or have symptoms suggesting ovarian dysfunction. It can also be relevant for individuals with a family history or risk factors for endocrine disorders or reproductive system cancers.

Understanding the results requires interpretation by a qualified healthcare professional. Elevated levels may prompt further investigation. Discuss your results with your doctor to understand their significance and any necessary follow-up steps.
03

Medical review status

Clinical review pending

A completed medical review is not recorded for this page. No clinician has endorsed the information shown here. Please discuss testing decisions with a qualified healthcare professional.

Meet the DNA Labs Kenya medical team →
04

A simple process

What happens next?

You do not have to navigate the test alone. We help you move from question to next step.

1

Speak with us

We check the test and answer your questions before collection.

2

Give your sample

Choose home collection or a coordinated hub visit in Kenya. We explain whether this test uses a cheek swab or blood draw.

3

Understand your report

A counselor helps you understand the result and the next steps.

05

Choose your collection

Home collection or a lab visit

We will explain the sample, preparation, and next steps before anything is collected.

Home collection

Choose a coordinated visit at home or another convenient location. Our team confirms the appointment and sample requirements in advance.

Lab or hub visit

Prefer to visit a coordinated location? We can guide you to the right hub and explain what to expect when you arrive.

Ask about locations →
PreparationNo special preparation is required for this test. Confirm with the laboratory before booking.
Sample2 mL (1 mL minimum) serum collected in a Serum Separator Tube (SST).
MethodologyConfirm with the laboratory before booking.
PrivacyYour sample and report are handled confidentially. Ask the team how your information is stored and shared.
Test results must be interpreted in the context of the patient's clinical history, symptoms, and other diagnostic findings. Abnormal results may require further investigation.
06

Read your report

What common result terms mean

PositiveA finding was identified. Your clinician or counselor will explain what it means for your care.
NegativeThe specific finding tested for was not identified. It does not rule out every possible cause.
VUSA variant was found, but current evidence is not enough to classify it. Your counselor can explain follow-up.
07

Questions people ask

Frequently asked questions

Inhibin A is a hormone produced mainly by the ovaries that plays a role in regulating the menstrual cycle and fertility.
This test helps assess ovarian function, monitor fertility treatments, and investigate potential reproductive system or endocrine disorders.
No special preparation, such as fasting, is typically required for this test. However, please confirm with the laboratory before booking.
Results should be interpreted by a healthcare professional in the context of your overall health and clinical picture. Elevated levels may indicate certain conditions and require further investigation.
Confirm with the laboratory before booking.
Confirm with the laboratory before booking.
08

Collaboration

Open for partnership with hospitals, clinics, doctors & researchers

Whether you are referring patients, building a research programme or supporting students, we work as an extension of your team — with responsive communication and clear scientific standards.

Hospitals & clinics

Referral pathways, coordinated sample logistics and shared reporting that fits your clinical workflow.

Doctors & specialists

LOINC-coded reports, ACMG-based variant classification and a direct scientific line for complex cases.

Research institutions

Sanger sequencing, NGS panels and custom assays — with project design support, batch pricing and agreed turnaround commitments.

Students & academic projects

Discounted laboratory services for college, master's and PhD research projects — including proposal guidance and cost-effective batch testing.

Explore partnerships
09

Trust & transparency

Sources, standards & how this page is maintained

Standards & references

  • ACMG/AMP technical standards for sequence variant interpretation
  • ClinGen curation and gene–disease validity frameworks where applicable
  • LOINC-coded reporting for interoperable results
  • ISO 9001:2015 quality management; ISO 15189 accreditation in progress

Page provenance

  • Last updated: September 27, 2026
  • Medical review: not yet completed
  • Written for patients & clinicians in Kenya; reviewed periodically against current guidance

Medical disclaimer: this page is general information, not a diagnosis or personal medical advice. Testing decisions and result interpretation should be made with a qualified healthcare professional.

Keep exploring

Related tests

View all tests →
Chat on WhatsApp